IndiaFilingsIndiaFilings
India FlagRegister India Company
UAE FlagRegister UAE Company
USA FlagRegister USA Company

NY VFXWAALA LLP

LLPIN : AAK-0263|ROC: RoC-MumbaiActive
Last Updated On : 11-08-2024
LLPINAAK-0263
LLP NameNY VFXWAALA LLP
Number of Partners2
Number of Designated Partners2
ROC CodeRoC-Mumbai
Date of Incorporation17-07-2017
Registered Address101,Chalet Amar,Juhu Devi CHS Ltd,Behind Criticare Hospital,Gulmohar Road No. 1 J VPD Scheme NA Mumbai City MUMBAI Maharashtra India 400049
Email ID[email protected]
Total Obligation of Contribution1,00,000
Main division of business activity to be carried out in India74
Description of main divisionREAL ESTATE,RENTING AND BUSINESS ACTIVITIES
Date of last financial year end for Statement of Accounts and Solvency2023-03-31
Date of last financial year end for Annual Return filed31-03-2024
LLP StatusActive

Directors / Signatory Details

DIN / PANNameBegin Date
01606535VISHAL VIRENDER DEVGAN17-07-2017
07032220NAVEEN SATULURI PAUL17-07-2017
NY VFXWAALA LLP is a Limited Liability Partnership (LLP) governed by the LLP Act, 2008. Registered under the Registrar of Companies RoC-Mumbai, it operates as a non-government entity. According to the Ministry of Corporate Affairs (MCA), this LLP was incorporated on 17-07-2017 and last updated on 11-08-2024. Its LLP Identification Number (LLPIN) is , and the registration number is . Currently, its eFiling status is listed as “Active” as per MCA records.
From a financial standpoint, NY VFXWAALA LLP has a total contribution of INR 1,00,000. Details of the latest financial filings, such as the Statement of Accounts and Solvency or Annual Returns, are unavailable, indicating limited publicly disclosed financial data.
The registered office address is 101,Chalet Amar,Juhu Devi CHS Ltd,Behind Criticare Hospital,Gulmohar Road No. 1 J VPD Scheme NA Mumbai City MUMBAI Maharashtra India 400049. Correspondence or inquiries may be sent to the official email address, [email protected].
For those interested in further details, below are some frequently asked questions: